Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dbv Technologies ADR
(NQ:
DBVT
)
0.7502
-0.0100 (-1.32%)
Streaming Delayed Price
Updated: 2:05 PM EDT, Sep 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Dbv Technologies ADR
< Previous
1
2
3
Next >
DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
July 31, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
July 25, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
July 19, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
July 10, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023
June 16, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming EAACI Congress 2023
June 08, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conference
June 06, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers
May 10, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conference
May 09, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Reports First Quarter 2023 Financial Results
May 04, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA
April 19, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting
April 12, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Ordinary and Extraordinary General Meeting of April 12, 2023
March 24, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Update
March 13, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old
March 07, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 Universal Registration Document
March 02, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
March 02, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
February 27, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming AAAAI 2023 Congress
February 21, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conference
February 10, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
January 23, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022
January 04, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
December 23, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022
December 08, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conference
November 22, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Highlight New Clinical Data at ACAAI 2022
November 09, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Reports Third Quarter Financial Results and Business Update
November 03, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update
October 31, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022
October 20, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors
October 03, 2022
From
DBV Technologies S.A.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.